In this issue, four articles highlight the critical role of nongenetic mechanisms and cell plasticity in mediating resistance to different classes of RAS inhibitors in pancreatic ductal adenocarcinoma and non–small cell lung cancer.

See related article by Benitz et al., p. 2162

See related article by Dilly et al., p. 2135

See related article by Araujo et al., p. 2183

See related article by Singhal et al., p. 2122

©2024 American Association for Cancer Research
2024
American Association for Cancer Research
You do not currently have access to this content.